NanoLight Technologies is a division of Prolume Ltd., a biotechnology company developing broad applications of natural, light-emitting marine proteins, or marine bioluminescence. The NanoLight division is focused on becoming the leader in high-value reagent & reporter systems for new product development in the pharmaceutical, agrichemical, and research products industries.
The company's mission is to enable their customers to evaluate and understand the mechanical performance of their materials on the micro- and nano-scales. With field experts in nanomechanical testing, data acquisition, system integration, and software development on their staff, tehy are well positioned to provide you with the most accurate results along with leading edge characterization.
NanoMedical Systems (NMS) is a startup company, which will commercialize the patented research of Dr. Mauro Ferrari at the University of Texas Health Science Center in Houston, a sponsored research site and a source of licensed IP for NMS. The company's Personalized Molecular Drug-delivery System (PMDS) is a small drug delivery device that is implanted subcutaneously (just under the skin) for slow and consistent release of a therapeutic agent over many weeks or months. A nanochannel delivery system (nDS) embodied on a silicon chip regulates the flow of therapeutic molecules.
Nanometics is a chemical research company dedicated to the development of novel raw materials for the personal care and textile industries. In addition, there are several ongoing collaborations in projects relating to biomedical imaging, chiral molecular switches for quantum computing and supramolecular chemistry for neural prosthetics.
Nanometrics' product lines offer an extensive array of proprietary technologies in optics, software and systems integration designed to meet the process control requirements of today's advanced semiconductor technologies.